COVID-19 and Convalescent Plasma

The FDA recently issued an emergency use authorization for convalescent plasma to treat Covid-19. The idea is that plasma from a donor who has recovered from Covid-19 has antibodies that can help treat patients who are now in the early stages of infection. Does this work? Are there any downsides to this emergency approval? Let’s find out.



Share on twitter
Share on facebook
Share on linkedin
Share on reddit
Share on email

Hidden information below


* indicates required
Email Format